| Company Name | Date | Purpose |
|
20 Microns
|
07-Nov-25
| 20 Microns Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 ,inter alia, to consider and approve To consider and approve Un-audited - Standalone & Consolidated - Financial Results of the Company for the quarter and half-year ended on September 30, 2025
|
|
21st Cent. Mgmt.
|
07-Nov-25
| Twentyfirst Century Management Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 inter alia to consider and approve Unaudited financial results of the company (Standalone and Consolidated) for the quarter ended 30th September 2025 alongwith the Limited Review Report from the Statutory Auditors of the company |
|
A.K.Capital Serv
|
07-Nov-25
| AK Capital Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 inter alia to consider and approve Un-audited financial results (Standalone & Consolidated) of the Company for the quarter and half year ended September 30 2025 and declaration of interim dividend on the equity shares of the Company for the financial year 2025-26 and to fix Record Date for the purpose of Interim Dividend if declared at the Board Meeting. |
|
Aadhar Hsg. Fin.
|
07-Nov-25
| Quarterly Results
Aadhar Housing Finance Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 ,inter alia, to consider and approve a. the Standalone and Consolidated Unaudited Financial Results along with the Limited Review Report of the Joint Statutory Auditors for the quarter ended 30th September, 2025. b. the modification of Borrowing sub-limits for the Company, issuance of Debentures and approval to create charge by way of mortgage and/or Hypothecation on various assets of the Company within the overall borrowing limit of the Company.
(As Per BSE Announcement Dated on 29.10.2025) |
|
Aarti Drugs
|
07-Nov-25
| Aarti Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 ,inter alia, to consider and approve Audited Financial Results for the quarter and half year ended September 30, 2025 |
| Prev | Next |